Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and ...

The national occupational health company promoted an executive in Overland Park to CEO. Startup's tool aims to cut down on ...

The deal includes outreach laboratory services in 13 states. Community Health Systems will continue to operate its inpatient and emergency department labs along with other hospital-based testing ...

Detailed price information for Ultragenyx Pharmaceu (RARE-Q) from The Globe and Mail including charting and trades.

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Quest Diagnostics Inc (DGX) reports a 15.2% revenue increase and raises full-year guidance amid robust performance and strategic expansions.

Shares of Quest Diagnostics Inc. rallied 7.08% to $178.24 Tuesday, on what proved to be an all-around favorable trading ...

Quest Diagnostics beat Q1 estimates with 15.2% revenue growth and lifted its 2025 guidance amid rising volumes and solid operating margins.

Quest Diagnostics is a leading provider of independent diagnostic testing in the United States thanks to its network of roughly 2,300 patient service centers across the country. We think its size and ...

DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.

Laboratory operator Quest Diagnostics raised its 2025 profit and revenue forecasts on Tuesday, banking on robust demand for its diagnostic tests, sending the company's shares up over 3% in premarket ...

Quest Diagnostics ranks first in Revenue Growth among its peers. It is second in Gross Profit and Return on Equity. The ...